Historical record - last NADAC effective date: 12/17/2014
Product Information
ROBITUSSIN COUGH-CHEST-CONG DM is a brand product labeled by Haleon US Holdings LLC, priced at $0.2267 per EA under NDC 00031871920. Its NADAC has been published 42 times since Dec 17, 2014.
Strength
10; 200 mg/1; mg/1
Manufacturer
Haleon US Holdings LLCNDC
00031871920
Classification
Brand
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
12/17/2014
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
5/23/2013
Pharmacological Classes
Price Statistics
The NADAC for ROBITUSSIN COUGH-CHEST-CONG DM has been published 42 times since Dec 17, 2014, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2267 per EA |
|---|---|
| All-time high | $0.2267 (Sep 30, 2015) |
| All-time low | $0.2267 (Dec 17, 2014) |
| Median price | $0.2267 |
| Average price | $0.2267 |
| Largest weekly change | 0.0% (Dec 24, 2014) |
| Weeks tracked | 42 |
| Tracking since | Dec 17, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Sep 30, 2015 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the dextromethorphan hydrobromide and guaifenesin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Haleon US Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
dextromethorphan hydrobromide and guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ROBITUSSIN COUGH-CHEST-CONG DM?
The current National Average Drug Acquisition Cost (NADAC) for ROBITUSSIN COUGH-CHEST-CONG DM, manufactured by Haleon US Holdings LLC, is $0.2267 per EA (NDC 00031871920), effective Sep 30, 2015.
How has the price of ROBITUSSIN COUGH-CHEST-CONG DM changed over time?
Over the history we have for it, the NADAC for ROBITUSSIN COUGH-CHEST-CONG DM has held within roughly two percent of its current level. It has been tracked across 42 weekly CMS publications since Dec 17, 2014.
What are the highest and lowest recorded NADAC prices for ROBITUSSIN COUGH-CHEST-CONG DM?
Since Dec 17, 2014, the NADAC for ROBITUSSIN COUGH-CHEST-CONG DM has ranged from a low of $0.2267 (Dec 17, 2014) to a high of $0.2267 (Sep 30, 2015), with a median of $0.2267 per EA.
Are there cheaper alternatives to ROBITUSSIN COUGH-CHEST-CONG DM?
No other NADAC-published product currently shares the active ingredient and strength of ROBITUSSIN COUGH-CHEST-CONG DM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ROBITUSSIN COUGH-CHEST-CONG DM?
ROBITUSSIN COUGH-CHEST-CONG DM (NDC 00031871920) is labeled by Haleon US Holdings LLC, and CMS classifies it as a brand product.